FDA Approves Pitolisant for Excessive Daytime Sleepiness in Pediatric Narcolepsy
June 25, 2024
The U.S. Food and Drug Administration has approved a new treatment ...
Read More
Adolescent and Adult Transitions From Major Depressive Disorder to Bipolar Disorder
June 21, 2024
Bipolar disorder (BD) often appears after onset of major depressive...
Read More
TMS Treatment Device Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
April 23, 2024
The FDA has recently granted clearance of a transcranial magnetic s...
Read More
Stimulants and Sleep Difficulties in Pediatric ADHD
March 28, 2024
A recent comprehensive study delved into the long-term effects of m...
Read More
CBT Helps Hyperactive Brain Circuits In Pediatric Patients With Anxiety Disorders
February 16, 2024
A new study reveals that cognitive behavioral therapy (CBT) normali...
Read More
Antipsychotic Medications and Mortality in Children and Young Adults
December 15, 2023
Children and young adults are commonly prescribed antipsychotics, p...
Read More
STAR-D For Adolescents?
December 8, 2023
Major depressive disorder (MDD) among adolescents carries high morb...
Read More
Highlights from 2023 NEI Congress: Child and Adolescent Psychiatry Academy
November 8, 2023
This year’s Child and Adolescent Psychiatry Academy included a seri...
Read More
Childhood Adversity and the Cortisol Awakening Response in Depression
August 3, 2023
The hypothalamic pituitary adrenal (HPA) axis is the main regulator...
Read More
Stimulant Treatment in Youth Not Associated With Substance Use Later in Life
July 16, 2023
Childhood attention-deficit/hyperactivity disorder (ADHD) is linked...
Read More
Escitalopram Approved for Generalized Anxiety Disorder in Children
May 21, 2023
The U.S. Food and Drug Administration has approved escitalopram for...
Read More
Long-Term Safety of Methylphenidate in Children and Adolescents with ADHD
April 29, 2023
Methylphenidate (MPH) is the most frequently prescribed treatment f...
Read More